Tempest Presents Data Supporting the Dual Mechanism of TPST-1495 as an Optimal Approach for Targeting the Prostaglandin Pathway in Cancer

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability